Clinical relevance of anti-interferon antibodies in the serum of chronic hepatitis C patients treated with interferon-α

Journal of Interferon and Cytokine Research

Volumn 17, Issue SUPPL. 1, 1997, Pages

  Bonino, Ferruccio ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERFERON ANTIBODY; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

ANTIBODY RESPONSE; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE COURSE; DRUG ANTIGENICITY; DRUG EFFICACY; HEPATITIS C; HUMAN; IMMUNOTHERAPY; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

ALANINE TRANSAMINASE; ANTIGEN-ANTIBODY REACTIONS; AUTOANTIBODIES; CHRONIC DISEASE; DRUG ADMINISTRATION SCHEDULE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HUMANS; INTERFERON TYPE I, RECOMBINANT;

HEPATITIS C VIRUS;

EID: 0030805855     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (3)

1. INGLADA, L., PORRES, J.S., LA BANDA, F., MORA, I., and CARRENO, V. (1987). Anti-IFN-alpha-titers during interferon therapy. Lancet 2, 1521.
2. DIBISCEGLIE, A.M., MARTIN, P., KASSIANIDES, C., LISKER-MELMAN, M., MURRAY, L., WAGGONER, J., GOODMAN, Z., BANKS, S.M., and HOOFNAGLE, J.H. (1989). Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N. Engl. J. Med. 321, 1506-1510.
3. ANTONELLI, G., CURRENTI, M., TURRIZIANI, O., and DIANZANI, F. (1991). Neutralizing antibodies to interferon-alpha: relative frequency in patients treated with different interferon preparations. J. Infect. Dis. 163, 882-885.